Copper Cu 64-ATSM

Known as: (64)Cu-ATSM, Copper-64-diacetyl-bis(N4-methylthiosemicarbazone) 
A radioconjugate consisting of a lipophilic copper(II)bis(thiosemicarbazone) labeled with the positron- and beta-emitting isotope (64)Cu with hypoxia… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
UNLABELLED (64)Cu-diacetyl-bis(N(4)-methylthiosemicarbazonate), (64)Cu-ATSM, continues to be investigated clinically as a PET… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
BACKGROUND Hypoxia and increased glycolytic activity of tumors are associated with poor prognosis. The purpose of this study was… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2012
2012
BACKGROUND The aim of this study was to compare (64)Cu-diacetyl-bis(N(4)-methylsemicarbazone) ((64)Cu-ATSM) and (18)FDG PET… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2009
2009
One of the positron emission radionuclides, (64)Cu, has been reported to be a particularly effective radioisotope in PET imaging… (More)
  • figure 1
  • figure 3
  • figure 4
  • table 1
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
UNLABELLED Tumor uptake of copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) (copper-ATSM), a hypoxia-targeting… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
UNLABELLED Cu-Diacetyl-bis(N(4)-methylthiosemicarbazone) (Cu-ATSM) is a recently developed PET imaging agent for tumor hypoxia… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2005
2005
BACKGROUND Cu-diacetyl-bis(N(4)-methylthiosemicarbazone) [Cu-ATSM] is a potential marker for tumor hypoxia that has been under… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
We have used copper-64-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (64Cu-PTSM) to radiolabel cells ex vivo for in vivo positron… (More)
Is this relevant?
2001
2001
Systemic administration of hypoxia-selective (64)Cu-diacetyl-bis(N(4)-methylthiosemicarbazone) ((64)Cu-ATSM) has increased… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Review
2001
Review
2001
Hypoxia in tumors has been related to poor response to conventional therapies. This paper will discuss the methods, both invasive… (More)
Is this relevant?